NUS Nu Skin Enterprises Inc

Price (delayed)

$34.36

Market cap

$1.71B

P/E Ratio

22.17

Dividend/share

$1.55

EPS

$1.55

Enterprise value

$1.98B

Founded more than 35 years ago, Nu Skin Enterprises, Inc. empowers innovative companies to change the world with sustainable solutions, opportunities, technologies and life-improving values. The company currently focuses its ...

Highlights
The price to earnings (P/E) is 20% less than the last 4 quarters average of 27.1 but 11% more than the 5-year quarterly average of 19.6
The quick ratio is down by 10% since the previous quarter but it is up by 9% year-on-year
The company's EPS fell by 44% YoY and by 26% QoQ
The net income has declined by 44% year-on-year and by 26% since the previous quarter

Key stats

What are the main financial stats of NUS
Market
Shares outstanding
49.91M
Market cap
$1.71B
Enterprise value
$1.98B
Valuations
Price to earnings (P/E)
22.17
Price to book (P/B)
1.9
Price to sales (P/S)
0.81
EV/EBIT
37.52
EV/EBITDA
11.83
EV/Sales
0.94
Earnings
Revenue
$2.1B
EBIT
$52.87M
EBITDA
$167.73M
Free cash flow
$18.18M
Per share
EPS
$1.55
Free cash flow per share
$0.37
Book value per share
$18.05
Revenue per share
$42.35
TBVPS
$31.29
Balance sheet
Total assets
$1.82B
Total liabilities
$931.68M
Debt
$498.89M
Equity
$892.97M
Working capital
$400.79M
Liquidity
Debt to equity
0.56
Current ratio
2.08
Quick ratio
0.82
Net debt/EBITDA
1.6
Margins
EBITDA margin
8%
Gross margin
71.3%
Net margin
3.7%
Operating margin
3.6%
Efficiency
Return on assets
4.2%
Return on equity
8.7%
Return on invested capital
3.8%
Return on capital employed
3.6%
Return on sales
2.5%
Dividend
Dividend yield
4.51%
DPS
$1.55
Payout ratio
100%

NUS stock price

How has the Nu Skin Enterprises stock price performed over time
Intraday
2.2%
1 week
-0.55%
1 month
-13.8%
1 year
-27.19%
YTD
-18.5%
QTD
-12.59%

Financial performance

How have Nu Skin Enterprises's revenue and profit performed over time
Revenue
$2.1B
Gross profit
$1.5B
Operating income
$74.77M
Net income
$77.44M
Gross margin
71.3%
Net margin
3.7%
The company's operating income has shrunk by 67% YoY and by 33% QoQ
Nu Skin Enterprises's operating margin has shrunk by 58% YoY and by 28% QoQ
The net income has declined by 44% year-on-year and by 26% since the previous quarter
The net margin has declined by 30% year-on-year and by 21% since the previous quarter

Growth

What is Nu Skin Enterprises's growth rate over time

Valuation

What is Nu Skin Enterprises stock price valuation
P/E
22.17
P/B
1.9
P/S
0.81
EV/EBIT
37.52
EV/EBITDA
11.83
EV/Sales
0.94
The company's EPS fell by 44% YoY and by 26% QoQ
The price to earnings (P/E) is 20% less than the last 4 quarters average of 27.1 but 11% more than the 5-year quarterly average of 19.6
The P/B is 38% below the 5-year quarterly average of 3.0 and 15% below the last 4 quarters average of 2.2
NUS's equity is down by 4.4% year-on-year
The price to sales (P/S) is 21% lower than the 5-year quarterly average of 1.0 and 12% lower than the last 4 quarters average of 0.9
NUS's revenue is down by 20% YoY and by 6% from the previous quarter

Efficiency

How efficient is Nu Skin Enterprises business performance
The return on invested capital has dropped by 78% year-on-year and by 42% since the previous quarter
The company's return on sales has shrunk by 70% YoY and by 38% QoQ
The company's return on equity fell by 42% YoY and by 25% QoQ
The ROA is down by 41% YoY and by 26% from the previous quarter

Dividends

What is NUS's dividend history
DPS
$1.55
Dividend yield
4.51%
Payout ratio
100%
Recent dividends

Financial health

How did Nu Skin Enterprises financials performed over time
The total assets is 96% more than the total liabilities
NUS's current ratio is up by 21% year-on-year
The quick ratio is down by 10% since the previous quarter but it is up by 9% year-on-year
The debt is 44% smaller than the equity
The debt to equity has grown by 12% year-on-year and by 6% since the previous quarter
The debt has increased by 6% year-on-year and by 4.2% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.